Home  >  News
Msc_Apr22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  EMA committee recommends approval of Sanofi’s Xenpozyme for acid sphingomyelinase deficiency,   May 21, 2022
  Voyager’s TRACER capsids demonstrate enhanced CNS transduction across species; new preclinical results bolster GBA1, Tau, SOD1 ALS gene therapy programmes,   May 20, 2022
  Invitae introduces expanded pharmacogenomics panel and specialized mental health panel,   May 20, 2022
  Janssen launches icare4u programme to improve lives of millions living with skin, joint and digestive disorders,   May 20, 2022
  Huawei collaborates with Wockhardt Foundation and NMMC to run Mobile Medical Clinic van,   May 20, 2022
  Institute of Medicine & Law launches ‘Dr Archana Sharma MedLegal Helpdesk’ to offer legal advice to doctors,   May 20, 2022
  Be Biopharma, Resilience enter collaboration to manufacture engineered B cells, a new class of cellular medicines,   May 20, 2022
  Bavarian Nordic secures contract from European country to supply Imvanex smallpox vaccine,   May 20, 2022
  Zomedica inks strategic investment and potential collaboration for VetGuardian monitoring product line,   May 20, 2022
  NIH announces antiviral drug development awards,   May 20, 2022
  Glenmark Pharma gets US FDA approval for generic Zytiga tablets,   May 20, 2022
  Aarti Drugs net up by only 6% to Rs. 55 crore in Q4,   May 20, 2022
  Dr Reddy’s Labs net profit dips by 76% in Q4, dividend at R. 30 per share,   May 20, 2022
  Mainz Biomed, Dante Labs ink partnership for commercialization of ColoAlert in Europe & UAE,   May 20, 2022
  Innovators urged to plan pre-approval for accelerated pathways in clinical studies,   May 20, 2022
  EMA accepts filing of MAA for Valneva’s inactivated Covid-19 vaccine candidate, VLA2001,   May 20, 2022
  Evotec, Almirall ink multi-target alliance in medical dermatology,   May 20, 2022
  CCI approves merger by absorption of Serum’s Covidshield Technologies into Biocon Biologics,   May 20, 2022
  Regrow Biosciences receives US FDA approval to begin phase II trials of Ossgrow to treat osteonecrosis,   May 20, 2022
  IAVI, Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development programme,   May 19, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |